---
document_datetime: 2025-12-29 08:17:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/zinbryta.html
document_name: zinbryta.html
version: success
processing_time: 0.1133263
conversion_datetime: 2025-12-29 23:03:29.283655
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Zinbryta

[RSS](/en/individual-human-medicine.xml/66265)

##### Withdrawn

This medicine's authorisation has been withdrawn

daclizumab Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Zinbryta](#news-on)
- [More information on Zinbryta](#more-information-on-zinbryta-649)
- [More information on Zinbryta](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 27 March 2018, the European Commission withdrew the marketing authorisation for Zinbryta (daclizumab beta) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Biogen Idec Ltd, which notified the European Commission of its decision to permanently discontinue the marketing of the product.

Zinbryta was granted marketing authorisation in the EU on 1 July 2016 for the treatment of relapsing forms of multiple sclerosis.

The European Public Assessment Report (EPAR) for Zinbryta is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Zinbryta : EPAR - Summary for the public

English (EN) (539.87 KB - PDF)

**First published:** 19/07/2016

**Last updated:** 02/05/2018

[View](/en/documents/overview/zinbryta-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-760)

български (BG) (623.68 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/bg/documents/overview/zinbryta-epar-summary-public_bg.pdf)

español (ES) (541.35 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/es/documents/overview/zinbryta-epar-summary-public_es.pdf)

čeština (CS) (551.54 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/cs/documents/overview/zinbryta-epar-summary-public_cs.pdf)

dansk (DA) (510.69 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/da/documents/overview/zinbryta-epar-summary-public_da.pdf)

Deutsch (DE) (543.23 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/de/documents/overview/zinbryta-epar-summary-public_de.pdf)

eesti keel (ET) (536.52 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/et/documents/overview/zinbryta-epar-summary-public_et.pdf)

ελληνικά (EL) (628.44 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/el/documents/overview/zinbryta-epar-summary-public_el.pdf)

français (FR) (542.84 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/fr/documents/overview/zinbryta-epar-summary-public_fr.pdf)

hrvatski (HR) (559.5 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/hr/documents/overview/zinbryta-epar-summary-public_hr.pdf)

italiano (IT) (536.25 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/it/documents/overview/zinbryta-epar-summary-public_it.pdf)

latviešu valoda (LV) (588.49 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/lv/documents/overview/zinbryta-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (563.73 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/lt/documents/overview/zinbryta-epar-summary-public_lt.pdf)

magyar (HU) (598.14 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/hu/documents/overview/zinbryta-epar-summary-public_hu.pdf)

Malti (MT) (591.98 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/mt/documents/overview/zinbryta-epar-summary-public_mt.pdf)

Nederlands (NL) (541.57 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/nl/documents/overview/zinbryta-epar-summary-public_nl.pdf)

polski (PL) (606.49 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/pl/documents/overview/zinbryta-epar-summary-public_pl.pdf)

português (PT) (541.48 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/pt/documents/overview/zinbryta-epar-summary-public_pt.pdf)

română (RO) (565.84 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/ro/documents/overview/zinbryta-epar-summary-public_ro.pdf)

slovenčina (SK) (588.64 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/sk/documents/overview/zinbryta-epar-summary-public_sk.pdf)

slovenščina (SL) (582.09 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/sl/documents/overview/zinbryta-epar-summary-public_sl.pdf)

Suomi (FI) (536.58 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/fi/documents/overview/zinbryta-epar-summary-public_fi.pdf)

svenska (SV) (537.64 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/sv/documents/overview/zinbryta-epar-summary-public_sv.pdf)

## Product information

Zinbryta : EPAR - Product Information

English (EN) (1.27 MB - PDF)

**First published:** 19/07/2016

**Last updated:** 28/06/2018

[View](/en/documents/product-information/zinbryta-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-508)

български (BG) (2.25 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/bg/documents/product-information/zinbryta-epar-product-information_bg.pdf)

español (ES) (1.32 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/es/documents/product-information/zinbryta-epar-product-information_es.pdf)

čeština (CS) (2.16 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/cs/documents/product-information/zinbryta-epar-product-information_cs.pdf)

dansk (DA) (1.31 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/da/documents/product-information/zinbryta-epar-product-information_da.pdf)

Deutsch (DE) (1.41 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/de/documents/product-information/zinbryta-epar-product-information_de.pdf)

eesti keel (ET) (1.23 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/et/documents/product-information/zinbryta-epar-product-information_et.pdf)

ελληνικά (EL) (2.63 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/el/documents/product-information/zinbryta-epar-product-information_el.pdf)

français (FR) (1.33 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/fr/documents/product-information/zinbryta-epar-product-information_fr.pdf)

hrvatski (HR) (2.81 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/hr/documents/product-information/zinbryta-epar-product-information_hr.pdf)

íslenska (IS) (1.08 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/is/documents/product-information/zinbryta-epar-product-information_is.pdf)

italiano (IT) (1.09 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/it/documents/product-information/zinbryta-epar-product-information_it.pdf)

latviešu valoda (LV) (1.88 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/lv/documents/product-information/zinbryta-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.16 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/lt/documents/product-information/zinbryta-epar-product-information_lt.pdf)

magyar (HU) (1.88 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/hu/documents/product-information/zinbryta-epar-product-information_hu.pdf)

Malti (MT) (1.91 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/mt/documents/product-information/zinbryta-epar-product-information_mt.pdf)

Nederlands (NL) (1.07 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/nl/documents/product-information/zinbryta-epar-product-information_nl.pdf)

norsk (NO) (1.11 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/no/documents/product-information/zinbryta-epar-product-information_no.pdf)

polski (PL) (1.87 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/pl/documents/product-information/zinbryta-epar-product-information_pl.pdf)

português (PT) (1.09 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/pt/documents/product-information/zinbryta-epar-product-information_pt.pdf)

română (RO) (1.22 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/ro/documents/product-information/zinbryta-epar-product-information_ro.pdf)

slovenčina (SK) (1.86 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/sk/documents/product-information/zinbryta-epar-product-information_sk.pdf)

slovenščina (SL) (1.88 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/sl/documents/product-information/zinbryta-epar-product-information_sl.pdf)

Suomi (FI) (1.33 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/fi/documents/product-information/zinbryta-epar-product-information_fi.pdf)

svenska (SV) (1.08 MB - PDF)

**First published:**

19/07/2016

**Last updated:**

28/06/2018

[View](/sv/documents/product-information/zinbryta-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0015 27/03/2018

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Zinbryta : EPAR - All Authorised presentations

English (EN) (477.64 KB - PDF)

**First published:** 19/07/2016

**Last updated:** 02/05/2018

[View](/en/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-174)

български (BG) (517.25 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/bg/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_bg.pdf)

español (ES) (481.09 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/es/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_es.pdf)

čeština (CS) (488.17 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/cs/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (459.95 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/da/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (479.68 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/de/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (483.13 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/et/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (518.75 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/el/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_el.pdf)

français (FR) (493.52 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/fr/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (488.31 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/hr/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (481.38 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/is/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_is.pdf)

italiano (IT) (481.24 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/it/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (511.88 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/lv/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (498.05 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/lt/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (510.29 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/hu/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (511.19 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/mt/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (480.33 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/nl/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (487.39 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/no/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_no.pdf)

polski (PL) (525.13 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/pl/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_pl.pdf)

português (PT) (480.86 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/pt/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_pt.pdf)

română (RO) (498.61 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/ro/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (508.81 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/sk/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (37.55 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/sl/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (480.09 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/fi/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (17.62 KB - PDF)

**First published:**

19/07/2016

**Last updated:**

02/05/2018

[View](/sv/documents/all-authorised-presentations/zinbryta-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Zinbryta Active substance daclizumab International non-proprietary name (INN) or common name daclizumab Therapeutic area (MeSH) Multiple Sclerosis Anatomical therapeutic chemical (ATC) code L04AC01

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

Zinbryta is indicated in adult patients for the treatment of relapsing forms of multiple sclerosis (RMS).

## Authorisation details

EMA product number EMEA/H/C/003862 Marketing authorisation holder

Biogen Idec Ltd

Innovation House

Opinion adopted 31/03/2016 Marketing authorisation issued 01/07/2016 Withdrawal of marketing authorisation 27/03/2018 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Zinbryta Article-20 referral - PRAC assessment report

Reference Number: EMA/779877/2017

English (EN) (241.57 KB - PDF)

**First published:** 12/01/2018

**Last updated:** 12/01/2018

[View](/en/documents/referral/zinbryta-article-20-referral-prac-assessment-report_en.pdf)

Zinbryta Article-20 referral - PRAC recommends further restrictions for multiple sclerosis medicine Zinbryta due to risk of serious liver damage

Reference Number: EMEA/H/A-20/1456/C/003862/0010

English (EN) (193.2 KB - PDF)

**First published:** 27/10/2017

**Last updated:** 27/10/2017

[View](/en/documents/referral/zinbryta-article-20-referral-prac-recommends-further-restrictions-multiple-sclerosis-medicine-zinbryta-due-risk-serious-liver-damage_en.pdf)

Zinbryta : EPAR - Procedural steps taken and scientific information after authorisation

Adopted

English (EN) (567.72 KB - PDF)

**First published:** 22/09/2016

**Last updated:** 28/06/2018

[View](/en/documents/procedural-steps-after/zinbryta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Zinbryta : EPAR - Scientific Conclusion

English (EN) (518.34 KB - PDF)

**First published:** 12/01/2018

**Last updated:** 02/05/2018

[View](/en/documents/scientific-conclusion/zinbryta-epar-scientific-conclusion_en.pdf)

Zinbryta-H-A20-1456-C-3862-0010 : EPAR - Assessment Report - Article 20

Reference Number: EMA/779877/2017

English (EN) (847.17 KB - PDF)

**First published:** 12/01/2018

**Last updated:** 02/05/2018

[View](/en/documents/variation-report/zinbryta-h-a20-1456-c-3862-0010-epar-assessment-report-article-20_en.pdf)

## Initial marketing authorisation documents

Zinbryta : EPAR - Public assessment report

Adopted

Reference Number: EMA/458317/2016

English (EN) (6.09 MB - PDF)

**First published:** 19/07/2016

**Last updated:** 02/05/2018

[View](/en/documents/assessment-report/zinbryta-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for Zinbryta

Adopted

Reference Number: EMA/CHMP/268320/2016

English (EN) (540.19 KB - PDF)

**First published:** 29/04/2016

**Last updated:** 02/05/2018

[View](/en/documents/smop-initial/chmp-summary-opinion-zinbryta_en.pdf)

#### News on Zinbryta

[EMA review of Zinbryta confirms medicine's risks outweigh its benefits](/en/news/ema-review-zinbryta-confirms-medicines-risks-outweigh-its-benefits) 18/05/2018

[EMA recommends immediate suspension and recall of multiple sclerosis medicine Zinbryta](/en/news/ema-recommends-immediate-suspension-recall-multiple-sclerosis-medicine-zinbryta) 07/03/2018

[EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders](/en/news/ema-urgently-reviewing-multiple-sclerosis-medicine-zinbryta-following-cases-inflammatory-brain-disorders) 02/03/2018

[EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage](/en/news/ema-concludes-review-zinbryta-confirms-further-restrictions-reduce-risk-liver-damage) 10/11/2017

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2017](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-23-26-october-2017) 27/10/2017

[PRAC recommends further restrictions for multiple sclerosis medicine Zinbryta due to risk of serious liver damage](/en/news/prac-recommends-further-restrictions-multiple-sclerosis-medicine-zinbryta-due-risk-serious-liver-damage) 27/10/2017

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 July 2017](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-july-2017) 07/07/2017

[EMA restricts use of multiple sclerosis medicine Zinbryta](/en/news/ema-restricts-use-multiple-sclerosis-medicine-zinbryta) 07/07/2017

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 April 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-25-28-april-2016) 29/04/2016

#### More information on Zinbryta

- [Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/search?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-1=1=EMEAHC0038620000) (initial marketing authorisation)

#### More information on Zinbryta

- [Zinbryta - referral](/en/medicines/human/referrals/zinbryta-0)
- [Zinbryta - referral](/en/medicines/human/referrals/zinbryta)

**This page was last updated on** 28/06/2018

## Share this page

[Back to top](#main-content)